| Year |
Citation |
Score |
| 2015 |
Beckmann JS, Meyer AC, Pivavarchyk M, Horton DB, Zheng G, Smith AM, Wooters TE, McIntosh JM, Crooks PA, Bardo MT, Dwoskin LP. r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement. Neurochemical Research. PMID 26227997 DOI: 10.1007/S11064-015-1680-4 |
0.738 |
|
| 2011 |
Wooters TE, Dwoskin LP, Bardo MT. Discriminative stimulus effects of NMDA, AMPA, and mGluR5 glutamate receptor ligands in methamphetamine-trained rats. Behavioural Pharmacology. 22: 516-24. PMID 21836462 DOI: 10.1097/Fbp.0B013E328349Aafa |
0.593 |
|
| 2011 |
Meyer AC, Horton DB, Neugebauer NM, Wooters TE, Nickell JR, Dwoskin LP, Bardo MT. Tetrabenazine inhibition of monoamine uptake and methamphetamine behavioral effects: locomotor activity, drug discrimination and self-administration. Neuropharmacology. 61: 849-56. PMID 21669212 DOI: 10.1016/J.Neuropharm.2011.05.033 |
0.697 |
|
| 2011 |
Wooters TE, Bardo MT. Methylphenidate and fluphenazine, but not amphetamine, differentially affect impulsive choice in spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley rats. Brain Research. 1396: 45-53. PMID 21570676 DOI: 10.1016/J.Brainres.2011.04.040 |
0.598 |
|
| 2011 |
Wooters TE, Smith AM, Pivavarchyk M, Siripurapu KB, McIntosh JM, Zhang Z, Crooks PA, Bardo MT, Dwoskin LP. bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse. British Journal of Pharmacology. 163: 346-57. PMID 21232049 DOI: 10.1111/J.1476-5381.2011.01220.X |
0.728 |
|
| 2011 |
Wooters TE, Bardo MT, Dwoskin LP, Midde NM, Gomez AM, Mactutus CF, Booze RM, Zhu J. Effect of environmental enrichment on methylphenidate-induced locomotion and dopamine transporter dynamics. Behavioural Brain Research. 219: 98-107. PMID 21219939 DOI: 10.1016/J.Bbr.2011.01.001 |
0.644 |
|
| 2011 |
Wooters TE, Walton MT, Bardo MT. Oral methylphenidate establishes a conditioned place preference in rats. Neuroscience Letters. 487: 293-6. PMID 20974224 DOI: 10.1016/J.Neulet.2010.10.040 |
0.555 |
|
| 2010 |
Smith AM, Pivavarchyk M, Wooters TE, Zhang Z, Zheng G, McIntosh JM, Crooks PA, Bardo MT, Dwoskin LP. Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release. Biochemical Pharmacology. 80: 402-9. PMID 20346923 DOI: 10.1016/J.Bcp.2010.03.018 |
0.711 |
|
| 2009 |
Wooters TE, Bevins RA, Bardo MT. Neuropharmacology of the interoceptive stimulus properties of nicotine. Current Drug Abuse Reviews. 2: 243-55. PMID 20443771 DOI: 10.2174/1874473710902030243 |
0.727 |
|
| 2009 |
Dwoskin LP, Smith AM, Wooters TE, Zhang Z, Crooks PA, Bardo MT. Nicotinic receptor-based therapeutics and candidates for smoking cessation. Biochemical Pharmacology. 78: 732-43. PMID 19523455 DOI: 10.1016/J.Bcp.2009.06.002 |
0.668 |
|
| 2009 |
Wooters TE, Bardo MT. Nicotinic receptors differentially modulate the induction and expression of behavioral sensitization to methylphenidate in rats. Psychopharmacology. 204: 551-62. PMID 19229521 DOI: 10.1007/S00213-009-1487-6 |
0.69 |
|
| 2008 |
Dwoskin LP, Wooters TE, Sumithran SP, Siripurapu KB, Joyce BM, Lockman PR, Manda VK, Ayers JT, Zhang Z, Deaciuc AG, McIntosh JM, Crooks PA, Bardo MT. N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity. The Journal of Pharmacology and Experimental Therapeutics. 326: 563-76. PMID 18460644 DOI: 10.1124/Jpet.108.136630 |
0.689 |
|
| 2008 |
Wooters TE, Neugebauer NM, Rush CR, Bardo MT. Methylphenidate enhances the abuse-related behavioral effects of nicotine in rats: intravenous self-administration, drug discrimination, and locomotor cross-sensitization. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 1137-48. PMID 17581534 DOI: 10.1038/Sj.Npp.1301477 |
0.764 |
|
| 2007 |
Wooters TE, Bardo MT. The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats. Behavioural Pharmacology. 18: 601-8. PMID 17912044 DOI: 10.1097/Fbp.0B013E3282Eff0D5 |
0.74 |
|
| 2006 |
Wooters TE, Dwoskin LP, Bardo MT. Age and sex differences in the locomotor effect of repeated methylphenidate in rats classified as high or low novelty responders. Psychopharmacology. 188: 18-27. PMID 16896959 DOI: 10.1007/S00213-006-0445-9 |
0.578 |
|
| Hide low-probability matches. |